This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
The company showcased three core programs developed through this platform
These medicines are essential in preventing RhD immunisation during pregnancy
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
The companies admitted taking part in the cartel in exchange for reduced fines but Alchem did not settle
Subscribe To Our Newsletter & Stay Updated
